☰

Meejeon Roh, Ph.D. - Publications

Affiliations: 
2001 University of Alabama, Birmingham, Birmingham, AL, United States 
Area:
Cell Biology
Tree Info Grants Similar researchers PubMed Report error

25 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2017 Unno K, Roh M, Yoo YA, Al-Shraideh Y, Wang L, Nonn L, Abdulkadir SA. Modeling African American prostate adenocarcinoma by inducing defined genetic alterations in organoids. Oncotarget. 8: 51264-51276. PMID 28881646 DOI: 10.18632/Oncotarget.17230  0.408
2017 Unno K, Roh M, Yoo YA, Al-Shraideh Y, Wang L, Nonn L, Abdulkadir SA. Modeling African American prostate adenocarcinoma by inducing defined genetic alterations in organoids. Oncotarget. PMID 28472770 DOI: 10.18632/oncotarget.17230  0.314
2016 Yoo YA, Roh M, Naseem AF, Lysy B, Desouki MM, Unno K, Abdulkadir SA. Bmi1 marks distinct castration-resistant luminal progenitor cells competent for prostate regeneration and tumour initiation. Nature Communications. 7: 12943. PMID 27703144 DOI: 10.1038/Ncomms12943  0.416
2016 Park SH, Ozden O, Liu G, Song HY, Zhu Y, Yan Y, Zou X, Kang HJ, Jiang H, Principe DR, Cha YI, Roh M, Vassilopoulos A, Gius D. SIRT2-mediated deacetylation and tetramerization of pyruvate kinase directs glycolysis and tumor growth. Cancer Research. PMID 27197174 DOI: 10.1158/0008-5472.Can-15-2498  0.392
2014 van der Meer R, Song HY, Park SH, Abdulkadir SA, Roh M. RNAi screen identifies a synthetic lethal interaction between PIM1 overexpression and PLK1 inhibition. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 20: 3211-21. PMID 24771642 DOI: 10.1158/1078-0432.Ccr-13-3116  0.404
2013 Abdulkadir S, Meer RV, Roh M. Abstract 5185: RNAi screen identifies a synthetic lethal interaction between Pim1 overexpression and Plk1 inhibition. Cancer Research. 73: 5185-5185. DOI: 10.1158/1538-7445.Am2013-5185  0.465
2012 Anderson PD, McKissic SA, Logan M, Roh M, Franco OE, Wang J, Doubinskaia I, van der Meer R, Hayward SW, Eischen CM, Eltoum IE, Abdulkadir SA. Nkx3.1 and Myc crossregulate shared target genes in mouse and human prostate tumorigenesis. The Journal of Clinical Investigation. 122: 1907-19. PMID 22484818 DOI: 10.1172/Jci58540  0.431
2012 Roh M, van der Meer R, Abdulkadir SA. Tumorigenic polyploid cells contain elevated ROS and ARE selectively targeted by antioxidant treatment. Journal of Cellular Physiology. 227: 801-12. PMID 21503880 DOI: 10.1002/Jcp.22793  0.359
2012 Anderson PD, McKissic SA, Logan M, Roh M, Franco O, Wang J, Doubinskaia I, Meer Rvd, Hayward S, Eischen C, Eltoum IA, Abdulkadir SA. Abstract 2983: Nkx3.1 and c-Myc co-regulate shared target genes involved in prostate cancer Cancer Research. 72: 2983-2983. DOI: 10.1158/1538-7445.Am2012-2983  0.441
2011 Wang J, Anderson PD, Luo W, Gius D, Roh M, Abdulkadir SA. Pim1 kinase is required to maintain tumorigenicity in MYC-expressing prostate cancer cells. Oncogene. 31: 1794-803. PMID 21860423 DOI: 10.1038/Onc.2011.371  0.457
2011 Kim J, Roh M, Doubinskaia I, Algarroba GN, Eltoum IE, Abdulkadir SA. A mouse model of heterogeneous, c-MYC-initiated prostate cancer with loss of Pten and p53. Oncogene. 31: 322-32. PMID 21685943 DOI: 10.1038/Onc.2011.236  0.428
2011 Roh M, Meer RVd, Abdulkadir S. Abstract 4206: Tumorigenic polyploid cells contain elevated levels of reactive oxygen species and are selectively targeted by antioxidant treatment Cancer Research. 71: 4206-4206. DOI: 10.1158/1538-7445.Am2011-4206  0.366
2011 McKissic S, Roh M, Abdulkadir S. Abstract 2401: Loss of Nkx3.1 cooperates with Myc overexpression to promote prostate tumorigenesis Cancer Research. 71: 2401-2401. DOI: 10.1158/1538-7445.Am2011-2401  0.459
2010 Kim J, Roh M, Abdulkadir SA. Pim1 promotes human prostate cancer cell tumorigenicity and c-MYC transcriptional activity. Bmc Cancer. 10: 248. PMID 20515470 DOI: 10.1186/1471-2407-10-248  0.422
2010 Roh M, Abdulkadir SA. Targeting the endothelin receptor in prostate cancer bone metastasis: Back to the mouse? Cancer Biology & Therapy. 9: 615-7. PMID 20150768 DOI: 10.4161/Cbt.9.8.11309  0.375
2010 Wang J, Kim J, Roh M, Franco OE, Hayward SW, Wills ML, Abdulkadir SA. Pim1 kinase synergizes with c-MYC to induce advanced prostate carcinoma. Oncogene. 29: 2477-87. PMID 20140016 DOI: 10.1038/Onc.2010.10  0.416
2010 Wang J, Kim J, Roh M, Franco OE, Martinez E, Hayward SW, Wills ML, Abdulkadir SA. Abstract 3239: Synergy of PIM1 kinase with c-MYC in prostate cancer Cancer Research. 70: 3239-3239. DOI: 10.1158/1538-7445.Am10-3239  0.374
2009 Kim J, Eltoum IE, Roh M, Wang J, Abdulkadir SA. Interactions between cells with distinct mutations in c-MYC and Pten in prostate cancer. Plos Genetics. 5: e1000542. PMID 19578399 DOI: 10.1371/Journal.Pgen.1000542  0.473
2008 Roh M, Franco OE, Hayward SW, van der Meer R, Abdulkadir SA. A role for polyploidy in the tumorigenicity of Pim-1-expressing human prostate and mammary epithelial cells. Plos One. 3: e2572. PMID 18596907 DOI: 10.1371/Journal.Pone.0002572  0.373
2006 Roh M, Kim J, Song C, Wills M, Abdulkadir SA. Transgenic mice for Cre-inducible overexpression of the oncogenes c-MYC and Pim-1 in multiple tissues. Genesis (New York, N.Y. : 2000). 44: 447-53. PMID 17013838 DOI: 10.1002/Dvg.20235  0.454
2005 Roh M, Song C, Kim J, Abdulkadir SA. Chromosomal instability induced by Pim-1 is passage-dependent and associated with dysregulation of cyclin B1. The Journal of Biological Chemistry. 280: 40568-77. PMID 16221667 DOI: 10.1074/Jbc.M509369200  0.367
2005 Roh M, Paterson AJ, Liu K, McAndrew J, Chin E, Kudlow JE. Proteolytic processing of TGFalpha redirects its mitogenic activity: the membrane-anchored form is autocrine, the secreted form is paracrine. Biochimica Et Biophysica Acta. 1743: 231-42. PMID 15843037 DOI: 10.1016/J.Bbamcr.2004.10.017  0.613
2004 Said-Al-Naief N, Roh M, Song C, Eltoum I, Gary B, Azuero R, Abdulkadir S. The expression of Pim-1 and Endothelin-1 in osteolytic and osteoblastic metastatic carcinoma to bone Oral Surgery, Oral Medicine, Oral Pathology, Oral Radiology, and Endodontology. 98: 201-202. DOI: 10.1016/J.Tripleo.2004.06.032  0.361
2002 Liu K, Paterson AJ, Konrad RJ, Parlow AF, Jimi S, Roh M, Chin E, Kudlow JE. Streptozotocin, an O-GlcNAcase inhibitor, blunts insulin and growth hormone secretion. Molecular and Cellular Endocrinology. 194: 135-46. PMID 12242036 DOI: 10.1016/S0303-7207(02)00155-7  0.561
2001 Roh M, Paterson AJ, Asa SL, Chin E, Kudlow JE. Stage-sensitive blockade of pituitary somatomammotrope development by targeted expression of a dominant negative epidermal growth factor receptor in transgenic mice Molecular Endocrinology. 15: 600-613. PMID 11266511 DOI: 10.1210/Mend.15.4.0625  0.602
Show low-probability matches.